Clinical Trials
4 trialsNCT01169532 2021-02-21
Ridaforolimus and Vorinostat in Treating Patients With Advanced Solid Tumors or Lymphoma
Fox Chase Cancer Center
Phase 1 Completed
NCT00874731 2019-05-06
MK-8669-037
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT01380184 2019-04-19
MK-8669-059
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT01605396 2019-03-25
MK-8669-064
Merck Sharp & Dohme LLC
Phase 2 Completed